care for a healthy life and improve the quality of life


Shineco, Inc. (“Shineco” or the “Company) aims to ’care for a healthy life and improve the quality of life’ by providing safe, efficient, and high-quality health products and services to society. Shineco has researched and developed 33 vitro diagnostic reagents and related medical devices to date, and the Company also produces and sells healthy and nutritious food.

Corporate Governance


Medical Device - POCT


Changzhou Biowin Pharmaceutical Co., Ltd., a subsidiary of Shineco, is mainly engaged in POCT testing business. According to the different types of diseases detected, POCT products can be divided into 15 series and 45 kinds of products. At present, 5 series and 24 kinds of products are sold domestically, and 10 series and 21 kinds of products are sold abroad. Biowin has 33 Chinese medical device registration certificates, as well as EU CE certificate, registration certificates in Australia, Spanish and Thai, Japanese product filing certificate, and other overseas certifications. Its products sell well on the German Amazon sales platform.
Official Website: Changzhou Biowin Pharmaceutical Co., Ltd.      Show More

PRESS RELEASES



FAQs




Shineco, Inc. was incorporated in the State of Delaware on August 20, 1997.

Shineco, Inc. completed its IPO on September 28, 2016.

The company's shares trade on NASDAQ under the ticker symbol SISI.

Jun 30.

Assentsure PAC
80 South Bridge Road, 06-02 Golden Castle Building, Singapore 058710
Website:https://assentsure.com.sg

Norton Rose Fulbright US LLP
1301 McKinney, Suite 5100, Houston, Texas 77010-3095, United States
Tel:+1 713 651 5594
Fax:+1 713 651 5246
Email:amelia.zhang@nortonrosefulbright.com

Transhare Cooperation
Bayside Center 1, 17755 North US Highway 19, Suite # 140, Clearwater FL 33764
Tel: 303-662-1112
Fax: 727-269-5616

CONTACT


SHINECO,INC.

secretary@shineco.tech

010-68130220






David J. Rudnick
+1- 917-864-8849